<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyEventTranscriptSummaryOutput xmlns:ns2="local" id="5177776"><Name>Q1 2014 Hi-Tech Pharmacal Earnings Conference Call</Name><Company>Hi-Tech Pharmacal Co Inc</Company><Drugs><Drug>hydrocodone polistirex + chlorpheniramine polistirex (extended-release capsule, cough/upper respiratory symptoms), Covidien</Drug><Drug>fluticasone propionate</Drug><Drug>buprenorphine (sublingual, opioid dependence), Indivior</Drug><Drug>flunisolide (oral aerosol inhalation, asthma), Acton Pharmaceuticals</Drug><Drug>dorzolamide hydrochloride</Drug></Drugs></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyEventTranscriptSummaryOutput>